Provided by Tiger Fintech (Singapore) Pte. Ltd.

Argenx SE

551.22
-26.6700-4.62%
Post-market: 551.220.00000.00%19:38 EDT
Volume:426.89K
Turnover:238.68M
Market Cap:33.66B
PE:34.59
High:574.50
Open:573.05
Low:550.91
Close:577.89
Loading ...

Earnings Estimates Rising for Argenx (ARGX): Will It Gain?

Zacks
·
18 Jan

Argenx price target raised to $717 from $670 at H.C. Wainwright

TIPRANKS
·
15 Jan

argenx Se : H.c. Wainwright Raises Target Price to $717 From $670

THOMSON REUTERS
·
15 Jan

argenx Price Target Raised to $700.00/Share From $660.00 by Truist Securities

Dow Jones
·
14 Jan

JMP Securities Remains a Buy on Argenx Se (ARGX)

TIPRANKS
·
14 Jan

argenx Se : Wedbush Raises Target Price to $715 From $665

THOMSON REUTERS
·
13 Jan

argenx Se : Truist Securities Raises Target Price to $700 From $660

THOMSON REUTERS
·
13 Jan

argenx Se : Jefferies Raises Target Price to $772 From $750

THOMSON REUTERS
·
13 Jan

Argenx SE Outlines 2025 Strategic Priorities Amid Strong Sales

TIPRANKS
·
13 Jan

Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Veru (VERU)

TIPRANKS
·
12 Jan

FDA Accepts J&J's Filing for Autoimmune Disease Drug Nipocalimab

Zacks
·
10 Jan

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading

MT Newswires Live
·
09 Jan

Argenx price target raised to $761 from $717 at BofA

TIPRANKS
·
07 Jan

Piper Sandler Remains a Buy on Argenx Se (ARGX)

TIPRANKS
·
07 Jan

Bank of America Securities Sticks to Their Buy Rating for Argenx Se (ARGX)

TIPRANKS
·
07 Jan

argenx Se : Guggenheim Raises Target Price to $775 From $665

THOMSON REUTERS
·
03 Jan

Argenx Secures Japanese Approval for VYVDURA in CIDP Treatment

TipRanks
·
28 Dec 2024

Wedbush Raises Argenx's Price Target to $665 From $655, Maintains Outperform Rating

MT Newswires Live
·
27 Dec 2024

argenx Se : Wedbush Raises Target Price to $665 From $655

THOMSON REUTERS
·
27 Dec 2024

Argenx announces Japan MHLW approval for Vyvdura for CIDP

TIPRANKS
·
27 Dec 2024